Medidata's 2014 guidance causes shares to dip; Qlucore and Nebion cross-promoting bioinformatics tools;

> Medidata ($MDSO) shares fell after the company posted 2014 guidance that fell short of analyst expectations. Results

> Bioinformatics firms Qlucore and Nebion are to promote each other's data analysis products. Article (reg. req.)

> BioClinica ($BIOC) could double its presence in Europe this year after strong performance in 2013. Release

> Texas A&M is using Datatrak's eClinical software for preclinical projects. Item

> Tech-focused CRO Clinipace reports it doubled its booking last year compared to 2012. News

> FDA surveys show changes to its website's search function have increased visitor satisfaction. Post

> Accelrys ($ACCL) has introduced a cloud-based drug discovery collaboration platform. Release

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.